An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence

Table 1

Patient demographics.

		(𝑛=115)
Female	n (%)	100 (87.0)
Male	n (%)	15 (13.0)
Age, years	Mean (range)	62.5 (30.5–80.3)
Body mass index, kg/m^2	Mean (range)	26.2 (16.6–41.5)

n: number of patients; %: percent of study analyzed safety population.